BillionToOne, Inc. SEC filings BLLN

BillionToOne, Inc. has 178 filings in SEC EDGAR's recent list, going back to Jun 20, 2025. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

BillionToOne, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement, New debt
Jun 29, 2026 Jun 23, 2026
8-K Current report
Material agreement, New debt
Jun 16, 2026 Jun 10, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
8-K Current report
Results of operations, Officer or director change
Mar 4, 2026 Mar 4, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Results of operations, Officer or director change
Dec 9, 2025 Dec 9, 2025
8-K Current report
Bylaw or fiscal year change, Other events
Nov 10, 2025 Nov 7, 2025

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BLLN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Menlo Park, CA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2070849

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.